Amgen Inc. (AMGN): A Bull Case Theory
We came across a bullish thesis on Amgen Inc. (AMGN) on Substack by Disruptive analytics. In this article, we will summarize the bulls’ thesis on AMGN. Amgen Inc.
Amgen Inc (AMGN)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | D E Shaw D. E. Shaw | 1,974,213 | $514,558,876 | +1087% | 0.37% |
| 2. | 1,675,500 | $436,702,320 | +66% | 0.07% | |
| 3. | Two Sigma Advisors John Overdeck And David Siegel | 1,545,600 | $402,845,184 | +97% | 0.93% |
| 4. | 1,214,800 | $316,625,472 | +16% | 0.05% | |
| 5. | Citadel Investment Group Ken Griffin | 524,503 | $136,706,462 | +6621% | 0.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $165.50 | 10 | Director | 3,582 | 2015-08-19 | Filing | |
| $166.64 | 3,000 | Director | 3,572 | 2015-08-19 | Filing | |
| $152.29 | 1,500 | Director | 2,000 | 2015-02-05 | Filing | |
| $152.29 | 1,500 | Director | 2,000 | 2015-02-05 | Filing | |
| $111.77 | 894 | Officer, Director | 185,013 | 2014-05-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $294.79 | 8,771 | Officer | 44,186 | 2025-02-11 | Filing | |
| $293.12 | 25,045 | Officer | 28,987 | 2025-02-07 | Filing | |
| $304.47 | 1,589 | Officer | 7,210 | 2025-02-05 | Filing | |
| $313.09 | 2,117 | Officer | 9,883 | 2024-05-03 | Filing | |
| $273.03 | 2,096 | Officer | 10,874 | 2023-12-04 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 52,721,795 | $13,741,408,650 | 0.23% | |
| 2. | 45,646,148 | $11,897,212,097 | 0.24% | |
| 3. | 29,434,414 | $7,671,590,422 | 0.3% | |
| 4. | 14,559,622 | $3,794,820,731 | 0.26% | |
| 5. | 13,205,604 | $3,441,908,597 | 0.63% |
News See All
10 Best Drug Stocks to Buy Now
Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for medicines in China.
Jim Cramer Discussed 10 Stocks Leading the Dow Higher in 2025
On Thursday, Jim Cramer, the host of Mad Money, drew attention to ten stocks that have been driving the performance of the Dow Jones Industrial Average in 2025.
Amgen Inc. (NASDAQ:AMGN) Q4 2024 Earnings Call Transcript
Operator: My name is Julienne, and I will be your conference facilitator today for Amgen's Fourth Quarter and Full Year 2024 Financial Results Conference Call.
10 Best Cancer Stocks to Buy According to Hedge Funds
Cancer is the second leading cause of death across the globe, second to cardiovascular disease.
7 Cheap Quarterly Dividend Stocks to Invest in
Growth stocks are typically seen as companies with the potential to outperform the market in the future, even if they are currently unprofitable or trading at high valuations.
Amgen Inc. (AMGN): A Bull Case Theory
We came across a bullish thesis on Amgen Inc. (AMGN) on Disruptive analytics’ Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on AMGN. Amgen Inc.
15 Best Cheap Stocks to Buy for 2025
The U.S. consumer prices report released this week revealed a less-than-expected increase in December, signaling a potential cooling in inflation pressures.
Louis Navellier's Top 15 Long-Term Stock Picks
Louis Navellier is a prominent American investor, author, and financial analyst, best known for his quantitative approach to stock selection and his long-standing track record in the investment industry...
13 Highest Yielding Dividend Stocks in the Dow
The Dow Jones Industrial Average, or simply the Dow, is one of the most well-known and influential stock market indices globally.
Billionaire Hedge Funds
